Table of Contents Author Guidelines Submit a Manuscript
Neural Plasticity
Volume 2015 (2015), Article ID 381964, 9 pages
http://dx.doi.org/10.1155/2015/381964
Research Article

Withaferin A Inhibits Nuclear Factor-κB-Dependent Pro-Inflammatory and Stress Response Pathways in the Astrocytes

Laboratory for Research on Neurodegenerative Disorders, IRCCS Fondazione Salvatore Maugeri, 27100 Pavia, Italy

Received 27 February 2015; Revised 1 July 2015; Accepted 2 July 2015

Academic Editor: Nicola Maggio

Copyright © 2015 Francesca Martorana et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Farina, F. Aloisi, and E. Meinl, “Astrocytes are active players in cerebral innate immunity,” Trends in Immunology, vol. 28, no. 3, pp. 138–145, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. R. M. Ransohoff and M. A. Brown, “Innate immunity in the central nervous system,” The Journal of Clinical Investigation, vol. 122, no. 4, pp. 1164–1171, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Rossi, “Astrocyte physiopathology: at the crossroads of intercellular networking, inflammation and cell death,” Progress in Neurobiology, vol. 130, pp. 86–120, 2015. View at Publisher · View at Google Scholar
  4. L. Brambilla, F. Martorana, and D. Rossi, “Astrocyte signaling and neurodegeneration: new insights into CNS disorders,” Prion, vol. 7, no. 1, pp. 28–36, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. Q. Zhang, R. Kang, H. J. Zeh III, M. T. Lotze, and D. Tang, “DAMPs and autophagy: cellular adaptation to injury and unscheduled cell death,” Autophagy, vol. 9, no. 4, pp. 451–458, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. C. K. Glass, K. Saijo, B. Winner, M. C. Marchetto, and F. H. Gage, “Mechanisms underlying inflammation in neurodegeneration,” Cell, vol. 140, no. 6, pp. 918–934, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Bsibsi, R. Ravid, D. Gveric, and J. M. van Noort, “Broad expression of Toll-like receptors in the human central nervous system,” The Journal of Neuropathology & Experimental Neurology, vol. 61, no. 11, pp. 1013–1021, 2002. View at Google Scholar · View at Scopus
  8. C. C. Bowman, A. Rasley, S. L. Tranguch, and I. Marriott, “Cultured astrocytes express toll-like receptors for bacterial products,” Glia, vol. 43, no. 3, pp. 281–291, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. P. A. Carpentier, W. S. Begolka, J. K. Olson, A. Elhofy, W. J. Karpus, and S. D. Miller, “Differential activation of astrocytes by innate and adaptive immune stimuli,” Glia, vol. 49, no. 3, pp. 360–374, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Bsibsi, C. Persoon-Deen, R. W. H. Verwer, S. Meeuwsen, R. Ravid, and J. M. Van Noort, “Toll-like receptor 3 on adult human astrocytes triggers production of neuroprotective mediators,” Glia, vol. 53, no. 7, pp. 688–695, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Hoshino, O. Takeuchi, T. Kawai et al., “Cutting edge: toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product,” Journal of Immunology, vol. 162, no. 7, pp. 3749–3752, 1999. View at Google Scholar · View at Scopus
  12. A. Poltorak, X. He, I. Smirnova et al., “Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene,” Science, vol. 282, no. 5396, pp. 2085–2088, 1998. View at Publisher · View at Google Scholar · View at Scopus
  13. S. T. Qureshi, L. Larivière, G. Leveque et al., “Endotoxin-tolerant mice have mutations in toll-like receptor 4 (Tlr4),” The Journal of Experimental Medicine, vol. 189, no. 4, pp. 615–625, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Gorina, M. Font-Nieves, L. Márquez-Kisinousky, T. Santalucia, and A. M. Planas, “Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88-dependent NFkappaB signaling, MAPK, and Jak1/Stat1 pathways,” Glia, vol. 59, no. 2, pp. 242–255, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. H. L. Pahl, “Activators and target genes of Rel/NF-κB transcription factors,” Oncogene, vol. 18, no. 49, pp. 6853–6866, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. D. Singh, A. Aggarwal, R. Maurya, and S. Naik, “Withania somnifera inhibits NF-kappaB and AP-1 transcription factors in human peripheral blood and synovial fluid mononuclear cells,” Phytotherapy Research, vol. 21, no. 10, pp. 905–913, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Kaileh, W. Vanden Berghe, A. Heyerick et al., “Withaferin A strongly elicits IκB kinase β hyperphosphorylation concomitant with potent inhibition of its kinase activity,” Journal of Biological Chemistry, vol. 282, no. 7, pp. 4253–4264, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Grover, A. Shandilya, A. Punetha, V. S. Bisaria, and D. Sundar, “Inhibition of the NEMO/IKKβ association complex formation, a novel mechanism associated with the NF-kappaB activation suppression by Withania somnifera's key metabolite withaferin A,” BMC Genomics, vol. 11, no. 4, article S25, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. V. Khedgikar, P. Kushwaha, J. Gautam et al., “Withaferin A: a proteasomal inhibitor promotes healing after injury and exerts anabolic effect on osteoporotic bone,” Cell Death and Disease, vol. 4, no. 8, article e778, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Maitra, M. A. Porter, S. Huang, and B. P. Gilmour, “Inhibition of NFkappaB by the natural product Withaferin A in cellular models of Cystic Fibrosis inflammation,” Journal of Inflammation, vol. 6, article 15, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. B. C. McFarland, S. W. Hong, R. Rajbhandari et al., “NF-κB-induced IL-6 ensures STAT3 activation and tumor aggressiveness in glioblastoma,” PLoS ONE, vol. 8, no. 11, Article ID e78728, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Lee, E.-R. Hahm, and S. V. Singh, “Withaferin A inhibits activation of signal transducer and activator of transcription 3 in human breast cancer cells,” Carcinogenesis, vol. 31, no. 11, pp. 1991–1998, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. K.-J. Min, K. Choi, and T. K. Kwon, “Withaferin A down-regulates lipopolysaccharide-induced cyclooxygenase-2 expression and PGE2 production through the inhibition of STAT1/3 activation in microglial cells,” International Immunopharmacology, vol. 11, no. 8, pp. 1137–1142, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. H. J. Um, K.-J. Min, D. E. Kim, and T. K. Kwon, “Withaferin A inhibits JAK/STAT3 signaling and induces apoptosis of human renal carcinoma Caki cells,” Biochemical and Biophysical Research Communications, vol. 427, no. 1, pp. 24–29, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. P. S. Frisa, M. N. Goodman, G. M. Smith, J. Silver, and J. W. Jacobberger, “Immortalization of immature and mature mouse astrocytes with SV40 T antigen,” Journal of Neuroscience Research, vol. 39, no. 1, pp. 47–56, 1994. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Martorana, L. Brambilla, C. F. Valori et al., “The BH4 domain of Bcl-X L rescues astrocyte degeneration in amyotrophic lateral sclerosis by modulating intracellular calcium signals,” Human Molecular Genetics, vol. 21, no. 4, pp. 826–840, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Rossi, L. Brambilla, C. F. Valori et al., “Focal degeneration of astrocytes in amyotrophic lateral sclerosis,” Cell Death & Differentiation, vol. 15, no. 11, pp. 1691–1700, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Gautron, P. Lafon, M. Chaigniau, G. Tramu, and S. Layé, “Spatiotemporal analysis of signal transducer and activator of transcription 3 activation in rat brain astrocytes and pituitary following peripheral immune challenge,” Neuroscience, vol. 112, no. 3, pp. 717–729, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Nakano, E. Furube, S. Morita, A. Wanaka, T. Nakashima, and S. Miyata, “Astrocytic TLR4 expression and LPS-induced nuclear translocation of STAT3 in the sensory circumventricular organs of adult mouse brain,” Journal of Neuroimmunology, vol. 278, pp. 144–158, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. E. Beurel and R. S. Jope, “Lipopolysaccharide-induced interleukin-6 production is controlled by glycogen synthase kinase-3 and STAT3 in the brain,” Journal of Neuroinflammation, vol. 6, article 9, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. Y.-J. Lee, D.-Y. Choi, I. S. Choi et al., “Inhibitory effect of a tyrosine-fructose Maillard reaction product, 2,4-bis(p-hydroxyphenyl)-2-butenal on amyloid-beta generation and inflammatory reactions via inhibition of NF-kappaB and STAT3 activation in cultured astrocytes and microglial BV-2 cells,” Journal of Neuroinflammation, vol. 8, article 132, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. X. Liu, Y. Tian, N. Lu, T. Gin, C. H. K. Cheng, and M. T. V. Chan, “Stat3 inhibition attenuates mechanical allodynia through transcriptional regulation of chemokine expression in spinal astrocytes,” PLoS ONE, vol. 8, no. 10, Article ID e75804, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. D. V. Kuprash, I. A. Udalova, R. L. Turetskaya, D. Kwiatkowski, N. R. Rice, and S. A. Nedospasov, “Similarities and differences between human and murine TNF promoters in their response to lipopolysaccharide,” Journal of Immunology, vol. 162, no. 7, pp. 4045–4052, 1999. View at Google Scholar · View at Scopus
  34. Y. Kim and S. M. Fischer, “Transcriptional regulation of cyclooxygenase-2 in mouse skin carcinoma cells. Regulatory role of CCAAT/enhancer-binding proteins in the differential expression of cyclooxygenase-2 in normal and neoplastic tissues,” Journal of Biological Chemistry, vol. 273, no. 42, pp. 27686–27694, 1998. View at Publisher · View at Google Scholar · View at Scopus
  35. S. T. Reddy, D. J. Wadleigh, and H. R. Herschman, “Transcriptional regulation of the cyclooxygenase-2 gene in activated mast cells,” The Journal of Biological Chemistry, vol. 275, no. 5, pp. 3107–3113, 2000. View at Publisher · View at Google Scholar · View at Scopus
  36. Q.-W. Xie, R. Whisnant, and C. Nathan, “Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon γ and bacterial lipopolysaccharide,” The Journal of Experimental Medicine, vol. 177, no. 6, pp. 1779–1784, 1993. View at Publisher · View at Google Scholar · View at Scopus
  37. M. T. Heneka, D. T. Golenbock, and E. Latz, “Innate immunity in Alzheimer's disease,” Nature Immunology, vol. 16, no. 3, pp. 229–236, 2015. View at Publisher · View at Google Scholar
  38. T. Philips and W. Robberecht, “Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease,” The Lancet Neurology, vol. 10, no. 3, pp. 253–263, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. P. Bezzi, G. Carmignoto, L. Pasti et al., “Prostaglandins stimulate calcium-dependent glutamate release in astrocytes,” Nature, vol. 391, no. 6664, pp. 281–285, 1998. View at Publisher · View at Google Scholar · View at Scopus
  40. P. Bezzi, M. Domercq, L. Brambilla et al., “CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity,” Nature Neuroscience, vol. 4, no. 7, pp. 702–710, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. V. L. Dawson, T. M. Dawson, E. D. London, D. S. Bredt, and S. H. Snyder, “Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures,” Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 14, pp. 6368–6371, 1991. View at Publisher · View at Google Scholar · View at Scopus
  42. S. R. Parathath, S. Parathath, and S. E. Tsirka, “Nitric oxide mediates neurodegeneration and breakdown of the blood-brain barrier in tPA-dependent excitotoxic injury in mice,” Journal of Cell Science, vol. 119, no. 2, pp. 339–349, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. R. Brambilla, V. Bracchi-Ricard, W.-H. Hu et al., “Inhibition of astroglial nuclear factor κB reduces inflammation and improves functional recovery after spinal cord injury,” The Journal of Experimental Medicine, vol. 202, no. 1, pp. 145–156, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. R. Brambilla, T. Persaud, X. Hu et al., “Transgenic inhibition of astroglial NF-κB improves functional outcome in experimental autoimmune encephalomyelitis by suppressing chronic central nervous system inflammation,” Journal of Immunology, vol. 182, no. 5, pp. 2628–2640, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. E. S. Fu, Y. P. Zhang, J. Sagen et al., “Transgenic inhibition of glial NF-kappa B reduces pain behavior and inflammation after peripheral nerve injury,” Pain, vol. 148, no. 3, pp. 509–518, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. R. Brambilla, G. Dvoriantchikova, D. Barakat, D. Ivanov, J. R. Bethea, and V. I. Shestopalov, “Transgenic inhibition of astroglial NF-κB protects from optic nerve damage and retinal ganglion cell loss in experimental optic neuritis,” Journal of Neuroinflammation, vol. 9, article 213, 2012. View at Publisher · View at Google Scholar · View at Scopus